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Abstract
Background: Low concentrations of serum zinc have been reported in HIV infected adults and are associated with
disease progression and an increased risk of death. Few studies have been conducted in HIV infected children in
Africa. We determined serum zinc levels and factors associated with zinc deficiency in HIV infected Ugandan
children.
Methods: We measured the baseline zinc status of 247 children aged 1-5 years enrolled in a randomised trial for
multiple micronutrient supplementation at paediatric HIV clinics in Uganda (http://ClinicalTrials.gov NCT00122941).
Zinc status was determined using inductively coupled atomic emission spectrophotometry (ICP-AES). Clinical and
laboratory characteristics were compared among zinc deficient (zinc <10.0 μmol/L) and non deficient children.
Logistic regression was used to determine predictors of low serum zinc.
Results: Of the 247 children, 134 (54.3%) had low serum zinc (< 10.0 μmol/L). Of the 44 children on highly active
antiretroviral therapy (HAART), 13 (29.5%) had low zinc compared to 121/203 (59.6%) who were not on HAART.
Overall, independent predictors of low zinc were fever (OR 2.2; 95%CI 1.1 - 4.6) and not taking HAART (OR 3.7; 95%
CI 1.8 - 7.6).
Conclusion: Almost two thirds of HAART naïve and a third of HAART treated HIV infected children were zinc
deficient. Increased access to HAART among HIV infected children living in Uganda might reduce the prevalence of
zinc deficiency.
Background
Zinc deficiency is wide spread in low-income countries
and is responsible for 4% of childhood deaths and 1% of
the burden of disease in Africa, Latin America and Asia
[1]. Populations in sub-Saharan Africa and South East
Asia have the greatest risk of zinc deficiency because of
inadequate zinc intake in about one third of the popula-
tion [2].
Zinc is a component of various metallo-enzymes, pro-
teins and cell membranes; and plays an important role
in immune regulation. Zinc deficiency increases suscept-
ibility to oxidative stress and impaired cell membrane
function [3,4]. In HIV infected adults, low serum zinc
has been associated with more advanced HIV disease
and increased mortality [5-7].
Whereas some studies of HIV infected children in
high-income countries have indicated that micronutrient
deficiencies are uncommon [8], the reverse is true in
low-income countries. The zinc status of HIV infected
children in Uganda has not been reported. In this paper
we report the magnitude of zinc deficiency and asso-
ciated factors in a group of HIV infected children in
Uganda.
Methods
Study sites
This study was part of a baseline assessment of children
enrolled in a multiple micronutrient supplementation
trial carried out between June 2005 and June 2008. This
paper presents data from 3 of 7 clinics involved in the
study, namely the paediatric HIV clinics at the national
referral hospital (Mulago), Mildmay Centre and Nsam-
bya hospital. These centres had laboratory facilities for
blood sampling and freezing before transportation for
analysis at a distant laboratory. Mulago is the national
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referral hospital; Mildmay Centre and Nsambya are pri-
vate, not-for-profit hospitals. All the three are situated
in the capital city, Kampala. The Mulago Hospital Pae-
diatric HIV Clinic is the largest in the country and cares
for more than 8000 patients. The Mildmay Centre,
Uganda, is an HIV/AIDS referral and training institu-
tion, 12 kilometres South of Kampala city centre and
cares for about 1500 HIV infected children, while
Nsambya hospital cares for an equal number of HIV
infected children.
Design and subjects
We here report the baseline zinc levels of children aged
1-5 years who enrolled in the multiple micronutrient
supplementation (MMS) study (ClinicalTrials.gov Identi-
fier: NCT00122941).
The MMS study was a randomised trial of a 14 vita-
mins and minerals versus a six multivitamin supplement
as ‘standard-of-care’ for 6 months, among 847 HIV
infected children, with a highly active anti-retroviral
therapy (HAART) strata comprising 10% of the study
participants. The study enrolled HIV infected children
who had at least attended the clinic once and were com-
ing for follow-up. Those who were enrolled in other stu-
dies were excluded.
Children in the HAART strata had already been
started on anti-retroviral therapy (ART) at the study
clinics before enrolment into the study. The 2006
World Health Organization (WHO) guidelines for
initiating anti-retroviral therapy in children had been
used, in addition to a ‘social criteria’ that was conduc-
tive for initiating ART. Children aged 1 - 3 years were
initiated on ART if their CD4+ T cell count was below
20% or if they had WHO stage 3 or 4 disease. Those
above 3 years of age were initiated on ART if their
CD4+ T cell count was < 15% or if they had WHO
stage 3 or 4 disease [9]. The social criteria meant that
the child had a consistent caretaker who was adherent
to previous clinic appointments, attended at least 2
counseling sessions on adherence to ART and had
consented for initiation of therapy.
Due to cost, zinc was analysed at baseline only for chil-
dren who had sufficient serum collected on both sam-
plings (baseline and at 6-month follow-up). Of the 847
children who participated in the multiple micronutrient
supplementation study, 705 were enrolled at the 3 sites
where zinc analysis was possible. Two hundred and forty
seven children of the 705 (35.0%) had complete clinical
data and laboratory analyses at baseline to be included in
this paper (figure 1). Laboratory data was declared
incomplete as long as a participant did not have one or
more of the tests. Out of the 458 exclusions, 261 children
had haematology and CRP results but no micronutrient
test (zinc inclusive) result, 64 had other micronutrient
tests done except zinc, 89 had baseline zinc results but
no second sample and 44 had missing samples. Overall
insufficient samples contributed 414/458 exclusions
while 44 were due to missing samples.
Ethical issues
Written informed consent from the mothers/caretakers
was obtained in English or Luganda, one of the com-
monly spoken local languages in the study area. Permis-
sion to conduct the study was granted by Makerere
University College of Health Sciences, the Mildmay
Centre, Nsambya and Mulago hospitals Research and
Ethics Committees. Permission was also granted by the
Uganda National Council for Science and Technology
and the Regional Committee for Medical and Health
Research Ethics, Western Norway ("REK Vest”). Coun-
selling for initiation of HAART and adherence was
offered to those who were eligible to start antiretroviral
therapy. Treatment for illness and prophylaxis was
offered according to the WHO and national paediatric
HIV management guidelines.
Procedures
History and physical examination
Mothers/caretakers were interviewed about the child’s
medical history, nutritional history and symptoms.
A detailed physical examination was conducted by one
of the study doctors. Weight was taken using a standar-
dized uniscale 01-410-15 to the nearest 0.1 kg and
height was taken using the Shorr portable infant/child
length/height (Shorr productions, Olney, Maryland,
USA) measuring board to the nearest 0.1 centimetre.
HIV/AIDS clinical disease staging was determined using
705 children enrolled at 3 urban sites 
(Mulago 500, Mildmay 167, Nsambya 38)
247 analysed for zinc
458 excluded due to 
incomplete lab data
Not on HAART
203
On HAART
44
847 HIV infected children 
enrolled in the 
multiple micronutrient supplementation study
Serum zinc 
<10.0 μmol/L
121
Serum zinc 
≥10.0 μmol/L
82
Serum zinc 
<10.0 μmol/L
13
Serum zinc 
≥10.0 μmol/L
31
142 at rural sites
Figure 1 Study profile.
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the World Health Organisation (WHO) classification for
paediatric HIV/AIDS [10].
Laboratory procedures
Three to 5 millilitres (ml) of blood was collected in a 5
ml trace element free vacutainer tube (Becton Dickin-
son, Franklin Lakes, N.J) by venepuncture from the
cubital fossa or dorsum of the hand irrespective of
when the last meal was eaten. The sample was centri-
fuged at 2000 g within one hour of collection. Serum
was transferred into trace element-free cryo-tubes, and
transported within 3 hours to a minus 20°C refrigera-
tor until shipment. Zinc was analysed using Inductively
Coupled Atomic Emission Spectrophotometry (ICP-
AES) [11] at the Clinical Chemistry Laboratory, Hau-
keland University Hospital, Bergen, Norway. The sam-
ples were digested using a microwave oven, nitric acid
and concentrated hydrogen peroxide, as described by
Rahil-Khazen et al [12]. The analytical coefficient of
variation was about 3 %. An additional 2 ml sample
was collected in an EDTA containing vacutainer tube
and analysed for haemoglobin, white cell count and
CD4+ T cell count within 12 hours of collection. A
complete blood count was performed using the Act
5Diff instrument (Beckman Coulter) and CD4 count
was done using a FACScan instrument and MultiSET
software (Beckman Dickinson). Qualitative C-reactive
protein (CRP) was measured using the latex immu-
noassay on one drop of serum (Human Gesellschaft
fur Biochemica und Diagnostica mbH, Germany). Dis-
tinct agglutination indicated a C-reactive protein (CRP)
content ≥ 6 mg/L. This rapid procedure was used in
order to feedback the result to the attending paediatri-
cian/doctor.
Low zinc was defined as a serum concentration below
10.0 μmol/L and an elevated CRP was defined as
≥6 mg/L. We used the WHO definition for anaemia
where by children aged 6 months to 5 years are consid-
ered to be anaemic if their haemoglobin levels are below
11 g/dl [13]. We did not adjust the haemoglobin levels
for ethnicity or altitude.
Statistical issues
Data were analysed using SPSS version 15. Categorical
characteristics were summarised into proportions while
continuous variables were analysed using means and
standard deviations. Demographic, anthropometry and
clinical characteristics were compared among zinc defi-
cient (zinc less than 10.0 μmol/L) and non deficient
children using Fisher’s exact test and odds ratios. All
factors with a p-value of less than 0.20 by bivariate ana-
lysis were retained in the multiple logistic regression
model to determine factors independently associated
with low zinc. Weight for height (WHZ), height for age
(HAZ) and weight for age (WAZ), z-scores were
calculated using the WHO Anthro software and refer-
ence population [14] to assess anthropometric status.
Results
Of the 247 children analysed for serum zinc, 134
(54.3%) had low zinc < 10μmol/L. Their mean (SD) age
was 33.4 (13.8) with a range of 12.0 to 65.5 months.
The male to female ratio was approximately 1:1.
Clinical and haematological findings
Generally the children were unhealthy. More than half
(141/247, 57.1%) had cough, which was the commonest
symptom, followed by skin rash in about half (121/247,
49.0%) and fever in a fifth (94/247, 17.8%) of the children.
More than half of the children (108/247, 53.0%) were
stunted, almost a quarter were underweight (53/247,
21.5%) and a tenth was wasted. Twenty five percent (62/
247) had advanced HIV disease with WHO stage 3 or 4.
Absolute CD4+ T cell count ranged from 46 - 3769 with a
mean (SD) of 1129(615). One third of the children (85/
247) were severely immune-compromised with CD4+ T
cell counts of less than 20%. Qualitative C-reactive protein
was elevated in 100 out of 247 (40.5%) children. The mean
haemoglobin (SD) was 9.9 (1.6) g/dl with a range of 4.6 -
13.7 g/dl. Two thirds of the children (170/247, 68.8%)
were anaemic with haemoglobin of less than 11 g/dl.
There were no differences in sex, age, anthropometry,
morbidity and CD4+ T cell count among those tested
for zinc versus those who were not tested.
Characteristics of children on HAART
The children receiving HAART were older with a mean
(SD) age of 42.3 (10.7) compared to the non-HAART
group with 31.4 (13.7) months. Other descriptive char-
acteristics were similar in HAART treated and HAART
naïve children as shown in table 1.
The proportion of HAART children who were tested for
zinc (44/85, 55.0%) was significantly higher (p = 0.00) than
the non-HAART (203/847, 32.5%) children analyzed for
zinc. The mean serum zinc among children on HAART
was 12.2 (SD 4.1) compared to 9.6 (SD 2.5) among those
not receiving HAART, a statistically significant difference
(OR 2.6; 95%CI 1.6 - 3.5). The mean duration of HAART
was 10.2 months for the 13 zinc deficient and 9.5 months
in children who were not zinc deficient, with a range of
one to 21 months. Of the 44 children, 33 (75%) had
received ART for 12 or more months.
Serum zinc and factors associated with low zinc
concentrations
The mean (SD) serum zinc concentration was 10.0 (2.9)
μmol/L with a range of 5.6 - 29.5 μmol/L. There was no
linear relationship between age, WHZ and haemoglobin
versus zinc status as shown in Figure 2, 3 and 4. In
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addition there was no significant difference in mean age,
anthropometry, haemoglobin and CD4+ cell count
among children with low serum zinc (< 10μmol/L) com-
pared to those with normal zinc levels (table 2).
Factors associated with low serum zinc concentrations
at bivariate analysis were: being HAART naïve, reported
fever, underweight, WHO stage 3 or 4 disease and ele-
vated CRP (table 3). The mean (SD) serum zinc among
CRP negative children was 10.2 (2.5) compared to 9.8
(3.6) in CRP positive children. This difference was not
statistically significant.
In the multivariate model the only significant indepen-
dent predictors of low zinc were: being HAART naïve
and reported fever. Of the 44 children on HAART, 13
(29.5%) had low serum zinc compared to 121 of 203
(59.6%) in the non-HAART group. This difference was
statistically significant [Adjusted OR 3.7 (95% CI 1.8-
7.7)]. When fever was excluded from the model elevated
CRP was a significant predictor of low zinc, illustrating
that fever and CRP are closely related.
Discussion
The prevalence of zinc deficiency in this group of HIV
infected children aged 1-5 years attending paediatric
HIV clinics in Uganda was high (54.3%). This was
higher than what was reported in a previous study of
children aged 6-36 months with persistent diarrhoea
but of undetermined HIV status at Mulago hospital,
Uganda [15]. While we used a cut off of 10 μmol/L to
indicate zinc deficiency, the previous study had used
4.73 μmol/L assuming a normal serum zinc level of
8.99 (SD 2.13) μmol/L measured from a control group
of healthy children. What was regarded as normal is
below the mean (SD) serum zinc of 10.0 (2.9) reported
in our study. An earlier community study in Kampala
had found a serum zinc range of 8.4 - 20.9μmol/L
[mean(SD) 10.1(3.2)] among children aged 4 -14 years
[16]. Based on these two previous studies, it is possible
that the zinc status in our study is similar to zinc
levels in the general population of children in a similar
age group in Uganda. The prevalence was twice as
high in children who had not yet started HAART com-
pared to those receiving HAART. This was not influ-
enced by the duration on HAART. This implies that
HAART may protect against zinc deficiency but will
not completely eliminate it.
Compared to other studies of HIV infected children in
Africa, the prevalence of zinc deficiency was higher than
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Figure 2 A scatterplot of age against zinc levels.
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Figure 3 A scatterplot of weight for height z-scores versus zinc
levels.
Table 1 Characteristics of HIV infected children aged 1-5 years by HAART status at paediatric HIV clinics in Uganda
Variable (mean, SD) HAART (n = 44) No HAART (n = 203) Mean difference (95% CI)
Age in months 42.3 (10.7) 31.4 (13.7) 10.9 (6.6 - 15.2)
Weight for height z score 0.7 (1.4) -0.2 (1.4) 0.9 (0.4 - 1.4)
Weight for age z score -0.7 (1.1) -1.3 (1.3) 0.6 (0.2 - 1.0)
Height for age z score -2.1 (1.4) -2.1 (1.6) 0.0 (-0.5 - 0.5)
Haemoglobin (g/dl) 10.9 (1.2) 9.8 (1.6) 1.1 (0.6 - 1.6)
Absolute CD4+ cell count (cells/μ L 1132 (664) 1128 (607) 6 (-198 - 206)
Serum zinc (μmol/L) 12.2 (4.1) 9.6 (2.5) 2.6 (1.6 - 3.5)
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what was reported in South Africa and Rwanda [17,18].
Our study had a larger sample size and older children
compared to the two studies which enrolled children
from 2 months of age.
We did not find any association between age and zinc
status in our study. All the children enrolled in this
study were above one year of age, very few of whom
were still breastfeeding. Other studies have shown that
micronutrient deficiencies are less likely to occur below
24 months of age [17] and that breastfeeding is protec-
tive [19] against low serum zinc. Further more, there
was no significant difference in mean zinc concentra-
tions between girls and boys. Similar findings were
reported from children whose HIV status was not
known in low-income families in California [20].
Surprisingly, there was no significant association
between zinc status and diarrhoea in the current study,
possibly because there were very few children with diar-
rhoea. Studies in other developing countries have shown
an association between low zinc and diarrhoea [21]. As
expected, the presence of fever was significantly asso-
ciated with low zinc levels. Fever is an indicator of
infection and this may be associated with increased
acute phase proteins and consequently reduced serum
zinc [22]. Other common illnesses such as cough and
skin rash were not associated with low zinc either.
There was a weak association between underweight
and zinc status although a previous Uganda study of
children with persistent diarrhoea [15] and a South
Africa study of HIV infected children [17] did not find
any association between zinc and nutritional status.
Some authors have shown that severely malnourished
children have a higher anti-oxidant activity and this is
associated with low serum zinc [19]. Although anaemic
children were more likely to have low zinc, the associa-
tion was not significant. Other studies in zinc deficient
low-income countries such as India and Cambodia have
reported a close association between zinc deficiency and
anaemia [19,23]. The lack of association in our study
could not be explained.
Advanced HIV disease (WHO stage 3 and 4) was asso-
ciated with low serum zinc but probably confounded by
other factors. Advanced HIV disease is more likely to be
associated with recurrent acute infections and an elevated
acute phase response interpreted as low zinc. Our find-
ings are similar to a South African study where the pre-
valence of zinc deficiency increased with HIV disease
staging [6]. CD4+ T cell count had no association with
zinc status in the current study. This finding is similar to
what was reported in studies of HIV infected adults at
Tufts university and Medical Centre in the nutrition for
health living cohort [24] and in South Africa [6].
Children who were on HAART were less likely to be
zinc deficient. This is further supported by a study in
adults that showed that patients receiving HAART have
better micronutrient indices including zinc than those
not yet on HAART [25]. However, two other studies
indicated that zinc deficiency remains highly prevalent
in HIV infected adults on HAART [7,24].
We acknowledge that infant, child feeding practices
and maternal HIV status influence the diet and mode of
feeding [26], and may subsequently affect zinc intake.
Adult studies have shown that the time of blood
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Figure 4 A scatterplot of haemoglobin against zinc levels.
Table 2 Characteristics of HIV infected children aged 1-5 years by zinc status at paediatric HIV clinics in Uganda
Variable (mean, SD) Serum zinc < 10 μmol/L 95% CI Serum zinc = 10 μmol/L 95% CI
Age in months 32.2 (14.0) 29.8 to 34.6 34.7 (13.6) 32.2 to 37.2
Weight for height
z score
-0.2 (1.4) -0.5 to 0.0 0.1 (1.5) -0.2 to 0.4
Weight for age z score -1.4 (1.3) -1.6 to -1.2 -1.0 (-1.3) -1.2 to -0.7
Height for age z score -2.3 (1.4) -2.5 to -2.0 -1.9 (1.8) -2.3 to -1.6
Haemoglobin (g/dl) 9.7 (1.7) 9.5 to 10.0 10.2 (1.5) 9.7 to 10.5)
Absolute CD4+ cell count (cells/μ L) 1056 (613) 950 to 1162 1214 (610) 1099 to 1330
*On HAART (n,%) 13 (29.5) 31 (70.5)
*Children on HAART are expressed as a percentage (%).
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collection and feeding influence zinc levels [27], factors
not controlled for in this study. The exclusions though
numerous, were not systematic and therefore less likely
to influence the results of our study. Low zinc levels
were associated with fever or CRP implying that infec-
tion and acute phase proteins may have influenced the
zinc status of the study children. Other researchers have
previously confirmed that serum zinc is affected by the
serum protein level and any acute-phase reactions [28].
Although the concentration of serum zinc gives limited
information on the total zinc content in the body, there
is no better way of determining zinc status that has
been established [29]. The generalisability of this study
is limited to the HIV infected children since we did not
have a control group of HIV un-infected children.
Coupled with the already existing poor nutritional and
immunological status, low zinc status in Ugandan HIV
infected children is likely to remain a significant contri-
butor to increased morbidity especially among those not
yet receiving HAART.
Conclusion
While almost two thirds of untreated HIV infected chil-
dren were zinc deficient, zinc deficiency occurred in
only a third of those on HAART. Increased access to
HAART among HIV infected children living in Uganda
might reduce the prevalence of zinc deficiency in this
population.
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Table 3 Factors associated with low zinc in 247 HIV infected Ugandan children aged 1-5 years
Variable No. of children Low zinc < 10μmol/L
(n; %)
Unadjusted OR (95%CI) p-value Adjusted OR (95%CI)
Age < 36 months
Age ≥ 36 months
146
101
86 (58.2)
49 (48.5)
1.5 (0.9 - 2.5) 0.153 1.0 (0.6 - 1.8)
Male
Female
128
119
75 (58.6)
59 (49.6)
1.4 (0.9 - 2.4) 0.162 0.7 (0.4 - 1.1)
On HAART
No HAART
44
203
13 (29.5)
121(59.6)
3.5 (1.7 - 7.1) 0.000 3.7 (1.8 - 7.7)
Reported fever
No fever
44
203
30 (68.2)
104 (51.2)
2.0 (1.0 - 4.1) 0.046 2.2 (1.1 - 4.6)
Current diarrhoea
No Diarrhoea
20
227
15 (75.0)
119 (52.4)
2.7 (1.0 - 7.7) 0.062 2.2 (0.8 - 6.7)
Cough present
No cough
141
106
81 (57.4)
53 (50.0)
1.4 (0.8 - 2.2) 0.249
WHO stage 3 or 4
WHO stage 1 or 2
62
185
42 (67.7)
92 (49.7)
2.1 (1.2 - 3.9) 0.018 1.5 (0.8 - 2.9)
WHZ score < -2
WHZ score ≥ -2
24
223
15 (62.5)
119 (53.4)
1.5 (0.6 - 3.5) 0.519
WAZ score < -2
WAZ score ≥ -2
56
191
38 (67.9)
96 (50.3)
2.1 (1.1 - 3.9) 0.022 1.2 (0.6 - 2.6)
HAZ score < -2
HAZ score ≥ -2
136
111
80 (58.8)
54 (48.6)
1.5 (0.9 - 2.5) 0.124 1.3 (0.8 - 2.3)
CRP < 6 mg/L
CRP ≥ 6 mg/L
147
100
72 (49.0)
62 (62.0)
1.7 (1.0 - 2.9) 0.051 1.6 (0.9 - 2.7)
Hb < 11 g/dl
Hb ≥ 11 g/dl
170
77
98 (57.6)
36 (46.8)
1.6 (0.9 - 2.7) 0.130 1.1 (0.6 - 2.0)
CD4 < 20%
CD4 ≥ 20%
85
162
52 (61.2)
82 (50.6)
1.5 (0.9 - 2.5) 0.139 1.1 (0.6 - 1.9)
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